| __timestamp | Catalent, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 334800000 | 17763000 |
| Thursday, January 1, 2015 | 337300000 | 22180000 |
| Friday, January 1, 2016 | 358100000 | 37257000 |
| Sunday, January 1, 2017 | 402600000 | 27367000 |
| Monday, January 1, 2018 | 462600000 | 64770000 |
| Tuesday, January 1, 2019 | 512000000 | 74986000 |
| Wednesday, January 1, 2020 | 577900000 | 79256000 |
| Friday, January 1, 2021 | 687000000 | 100156000 |
| Saturday, January 1, 2022 | 844000000 | 131408000 |
| Sunday, January 1, 2023 | 831000000 | 152946000 |
| Monday, January 1, 2024 | 935000000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Catalent, Inc. and Dynavax Technologies Corporation, two prominent players, showcase contrasting strategies over the past decade. From 2014 to 2023, Catalent's SG&A expenses surged by approximately 179%, reflecting its aggressive expansion and investment in operational capabilities. In contrast, Dynavax's expenses grew by about 760%, indicating a significant scale-up in its operations, albeit from a smaller base.
While Catalent's expenses peaked in 2024, Dynavax's data for the same year remains unavailable, leaving room for speculation on its strategic direction. This comparison highlights the diverse approaches companies take in optimizing costs, with Catalent focusing on steady growth and Dynavax on rapid scaling. Understanding these trends offers valuable insights into their financial health and strategic priorities.
Comparing SG&A Expenses: AbbVie Inc. vs Catalent, Inc. Trends and Insights
BeiGene, Ltd. vs Dynavax Technologies Corporation: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Catalent, Inc. vs Walgreens Boots Alliance, Inc.
Breaking Down SG&A Expenses: Catalent, Inc. vs Veracyte, Inc.
Who Optimizes SG&A Costs Better? Opthea Limited or Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Verona Pharma plc vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: ADMA Biologics, Inc. vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Dynavax Technologies Corporation Trends and Insights
Breaking Down SG&A Expenses: Viking Therapeutics, Inc. vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Dynavax Technologies Corporation vs Evotec SE
Who Optimizes SG&A Costs Better? Dynavax Technologies Corporation or Viridian Therapeutics, Inc.